#22193
#22194
Re: Farmas USA
hello, putadon de AMRN....
empiezan las revisiones de PO, Cannacord lo baja de 26 a 19$
#22195
Re: Farmas USA
#22196
Re: Farmas USA
#22197
Re: Farmas USA
#22198
Re: Farmas USA
AMRN Acabo de sacar del garage la tienda, el saco de dormir, el camping gas, las piketas, catimplota, cuerdas, machete......y 5k para meterle un tiro de GRACIA y esperar sentado el BO.
Tengo lo fundamental,buen precio, posibilidad de promediar acojonante y TRANQULIDAD Y PACIENCIA.
AMRN BO sure.
#22199
Re: Farmas USA
NADA HA CAMBIADO
Citigroup Reiterates Buy Rating, $20 PT on Amarin Corporation
10:09a ET December 7, 2012 (Benzinga)
In a report published Friday, Citigroup reiterated its Buy rating and $20.00 price target on Amarin Corporation (NASDAQ: AMRN).
Citigroup noted, “We were not surprised by AMRN's initiation of hiring a Vascepa salesforce based on prior management guidance. However, we believe the concurrent establishment of a $100M debt instrument despite ending 3Q with $215M in cash will inject added uncertainty around both next Friday‘s (12/14) expected FDA exclusivity decision for Vascepa getting NCE, and the relative interest level of potential partners. We expect these actions to increase the nearterm speculation and volatility for AMRN shares, however our projections for Vascepa are unchanged as we previously valued AMRN based on a stand-alone scenario.”
#22200